REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 15th, 2024 • Neuraxis, INC • Electromedical & electrotherapeutic apparatus • Florida
Contract Type FiledFebruary 15th, 2024 Company Industry JurisdictionThis Registration Rights Agreement (this “Agreement”) is made and entered into as of February [ ], 2024 between by and between Neuraxis, Inc., a Delaware corporation (the “Company”) and [the Investor], a [State] [Individual] [Entity] (“Investor”).
ContractConvertible Promissory Note • February 15th, 2024 • Neuraxis, INC • Electromedical & electrotherapeutic apparatus • Florida
Contract Type FiledFebruary 15th, 2024 Company Industry JurisdictionTHIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 15th, 2024 • Neuraxis, INC • Electromedical & electrotherapeutic apparatus • Florida
Contract Type FiledFebruary 15th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of February [ ], 2024, is entered into by and between Neuraxis, Inc., a Delaware corporation (the “Company”) and [the Investor], a [State] [Individual] [Entity] (“Investor”).
FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 15th, 2024 • Neuraxis, INC • Electromedical & electrotherapeutic apparatus
Contract Type FiledFebruary 15th, 2024 Company IndustryThis FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT (this “Amendment”) is dated effective as of February 12, 2024 (the “Amendment Effective Date”), by and between Neuraxis, Inc., a Delaware corporation (the “Company”) and Flagstaff International, LLC, a Delaware limited liability company (“Investor”). (the “Investor,” and together with the Company, the “Parties”).